Successful long-term management of severe psoriasis with secukinumab after autologous hematopoietic stem cell transplantation for multiple myeloma: a case report
Authors:
- Roberto Bueno-FilhoRBRoberto Bueno-Filho
- Lluís PuigLPLluís Puig
- Marina CoutinhoMCMarina Coutinho
Open Access
- 12 November 2026
- journal article
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (6)
Abstract
No abstract availableFunding Information
- Fundação de Apoio ao Ensino, Pesquisa e Assistência
This publication has 9 references indexed in Scilit:
- [Translated article] Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and PsoriasisActas Dermo-Sifiliograficas, 2024
- Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysisFrontiers in Immunology, 2023
- Stem cell therapy as a potential treatment option for psoriasisAnais Brasileiros de Dermatologia, 2022
- Human skin-resident host T cells can persist long term after allogeneic stem cell transplantation and maintain recirculation potentialScience Immunology, 2022
- Evaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantationTransfusion and Apheresis Science, 2021
- Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple MyelomaCells, 2021
- Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaLeukemia, 2015
- Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantationJournal of the American Academy of Dermatology, 2013
- Complete Remission of Psoriasis After Autologous Hematopoietic Stem-Cell Transplantation for Multiple MyelomaJournal of Clinical Oncology, 2008